title: Persistence of peri-neural granulomas after successful treatment of leprosy.
authors.forename: R J
authors.initials: RJ
authors.lastname: Ludwig
authors.forename: U
authors.initials: U
authors.lastname: Henke
authors.forename: M
authors.initials: M
authors.lastname: Wolter
authors.forename: S L
authors.initials: SL
authors.lastname: Walker
authors.forename: C
authors.initials: C
authors.lastname: Brandt
authors.forename: T A
authors.initials: TA
authors.lastname: Wichelhaus
authors.forename: S
authors.initials: S
authors.lastname: Kramme
authors.forename: D N J
authors.initials: DN
authors.lastname: Lockwood
authors.forename: R
authors.initials: R
authors.lastname: Kaufmann
mesh_terms: D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D006099:Granuloma / Q000175:diagnosis*; D006801:Humans; D007917:Leprostatic Agents / Q000627:therapeutic use; D007918:Leprosy / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D015242:Ofloxacin / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use; D012871:Skin Diseases / Q000175:diagnosis*
chemical_list: D007917:Leprostatic Agents; D015242:Ofloxacin; D012293:Rifampin